Hippocampus -- Redox dysregulation in schizophrenia: Genetic susceptibility and pathophysiological mechanisms -- An overview and current perspective on family studies of schizophrenia -- Synaptic vesicle associated proteins and schizophrenia -- Cortical dopamine in schizophrenia -- G72/g30 in neuropsychiatric disorders -- Cholinergic mechanisms in schizophrenia -- The neurobiology of negative symptoms and the deficit syndrome -- Alterations of neurotransmitter receptors in schizophrenia: Evidence from postmortem studies -- Auditory cortex anatomy and asymmetry in schizophrenia -- Event related potentials (ERPS) in the study of schizophrenia: How pre-clinical ERP studies have contributed to our understanding of schizophrenia -- Neuregulin 1 and schizophrenia -- The role of prefrontal abnormalities in schizophrenia -- Early-stage visual processing deficits in schizophrenia and implications for higher level function -- Magnetic resonance spectroscopy -- Dysbindin-1 and its protein family -- Glutamate and schizophrenia: Phencyclidine, n-methyl-d-aspartate (NMDA) receptors: Etiology and treatment.